Stay updated with breaking news from Tyler Binney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Intrinsic Therapeutics, Inc., the developer of the Barricaid, an FDA approved medical device proven to significantly reduce reherniations and...
Slated to close in the first quarter of 2024, the deal could include “additional contingent payments” based on Relievant’s sales.
Relievant Medsystems released the Intracept Simulator System, a training program for the Intracept procedure, the company said Sept. 21.
Relievant Medsystems announced today that it released its Intracept simulator system, a training platform for the Intracept procedure.
Boston Scientific (NYSE:BSX) announced today that it entered into a definitive agreement to acquire Relievant Medsystems.